Učitavanje...
The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.
Spremljeno u:
| Izdano u: | Clin Case Rep |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7495745/ https://ncbi.nlm.nih.gov/pubmed/32983485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2967 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|